1. Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
   Noah M. Hahn et al, 2006, Clinical Cancer Research CrossRef
2. Metronomic Chemotherapy in Prostate Cancer
   Piotr J. Wysocki et al, 2022, Journal of Clinical Medicine CrossRef
3. CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
   Xi Chen et al, 2022, Frontiers in Endocrinology CrossRef